Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Jul 22;20(10):2150–2159. doi: 10.1158/1055-9965.EPI-11-0344

Figure 2.

Figure 2

Multivariate hazard ratios for prostate cancer-specific mortality per 1 standard deviation increase in census tract-level concentrated disadvantage for 833 men diagnosed with prostate cancer between 1986 and 1990, private sector vs. Veterans Health Administration healthcare system: Chicago area. Hazard ratios are adjusted for age, tumor characteristics, first-course treatment, Charlson comorbidity score, and in the case for all patients in either healthcare setting, race/ethnicity. Note: SD = standard deviation, CD = concentrated disadvantage, AA = African Americans, WNH = White, Non-Hispanic, and CI = confidence interval.